KAZIA (NASDAQ: KZIA) CEO receives 150K RSUs and 500K stock options grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
KAZIA THERAPEUTICS LTD Chief Executive Officer John E. Friend II received new equity compensation awards in the form of restricted share units and stock options tied to the company’s ADSs. These are grants, not open-market purchases.
The awards include 150,000 restricted share units, each representing a contingent right to receive one ADS, and 500,000 employee stock options with an exercise price of $6.78 per ADS. One-third of both the RSUs and options vest on January 8, 2027, with the remaining two-thirds vesting in equal yearly tranches on each anniversary thereafter. The options were granted for no cash consideration and expire on January 8, 2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Friend John E. II
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 500,000 | $0.00 | -- |
| Grant/Award | Restricted Share Units | 150,000 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 500,000 shares (Direct, null);
Restricted Share Units — 150,000 shares (Direct, null)
Footnotes (1)
- Represents a board-approved award of 500,000 options over ADSs, approved by the Remuneration Committee on January 8, 2026, at an exercise price of $6.78 per ADS, which was set by reference to the closing price of the Issuer's ADSs on Nasdaq on January 8, 2026. One-third of the options vest on January 8, 2027 (the "Commencement Date") and the remaining two-thirds vest in equal yearly tranches on the anniversary of the Commencement Date. The options were granted for no consideration and expire on January 8, 2029. Represents a board-approved award of 150,000 restricted share units ("RSUs"), approved by the Remuneration Committee on January 8, 2026. One-third of the RSUs vest on January 8, 2027, and the remaining two-thirds vest in equal yearly tranches thereafter. Each RSU represents a contingent right to receive one ADS of the Issuer.
Key Figures
RSU grant size: 150,000 RSUs
Option grant size: 500,000 options
Option exercise price: $6.78 per ADS
+4 more
7 metrics
RSU grant size
150,000 RSUs
Board-approved award to CEO on January 8, 2026
Option grant size
500,000 options
Employee stock options over ADSs to CEO
Option exercise price
$6.78 per ADS
Set by reference to Nasdaq closing price on January 8, 2026
Option expiration date
January 8, 2029
Expiry of 500,000 employee stock options
Initial vesting date
January 8, 2027
One-third of RSUs and options vest on this date
Underlying ADSs from RSUs
150,000 ADSs
Each RSU equals one ADS upon vesting
Underlying ADSs from options
500,000 ADSs
Shares purchasable upon option exercise at $6.78
Key Terms
Restricted Share Units, ADSs, Employee Stock Option (right to buy), exercise price, +2 more
6 terms
ADSs financial
"each RSU represents a contingent right to receive one ADS of the Issuer."
Employee Stock Option (right to buy) financial
"Represents a board-approved award of 500,000 options over ADSs,"
exercise price financial
"at an exercise price of $6.78 per ADS, which was set by reference"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Remuneration Committee financial
"approved by the Remuneration Committee on January 8, 2026,"
A remuneration committee is a group of independent board members who design, approve and oversee pay packages for a company’s executives and directors. Think of them as the household budget planners for top management: they decide salaries, bonuses and stock awards so pay rewards performance and limits excessive risk. For investors, their role matters because compensation policies affect management incentives, business strategy and the long‑term value shareholders receive.
vest financial
"One-third of the RSUs vest on January 8, 2027, and the remaining two-thirds vest"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What equity awards did KAZIA (KZIA) CEO John E. Friend II receive?
John E. Friend II received 150,000 restricted share units and 500,000 employee stock options over KAZIA ADSs. These board-approved grants form part of his equity compensation and are not open-market share purchases.
What is the exercise price of the new KAZIA (KZIA) stock options?
The 500,000 employee stock options were granted with an exercise price of $6.78 per ADS. This price was set by reference to the closing price of KAZIA’s ADSs on Nasdaq on January 8, 2026.
How do the KAZIA (KZIA) CEO’s new RSUs and options vest?
One-third of both the 150,000 RSUs and 500,000 options vest on January 8, 2027. The remaining two-thirds vest in equal yearly tranches on each anniversary of that date, creating a multi‑year vesting schedule.
When do the new KAZIA (KZIA) CEO stock options expire?
The 500,000 employee stock options granted to the CEO expire on January 8, 2029. If not exercised by that date at the $6.78 per ADS strike price, the options will lapse and no longer be exercisable.
Did the KAZIA (KZIA) CEO pay cash for these RSU and option awards?
The filing states the 500,000 options were granted for no consideration, meaning the CEO did not pay cash to receive them. The 150,000 RSUs similarly represent a contingent right to ADSs as part of his compensation.